The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
At the CVC, creative ideas and cutting-edge technology help to shape the treatments of tomorrow. The CVC research focuses on preserving cardiac function over time and ranges from basic and translational studies to multicentre clinical trials. The CVC researchers investigate the mechanisms underlying CVD, translate these findings into new treatments, and develop patient-tailored therapies. Our research focuses on:
CVD is the leading cause of morbidity and mortality, with ageing being a primary risk factor. The prevalence of CVD will only further increase due to the ageing of our population. This is particularly relevant for the northern Netherlands, a region with a high prevalence of cardiovascular risk factors and unfavourable socioeconomic circumstances.
The CVC researchers and physicians are well-embedded in societal organizations, which ensures that the research results are timely implemented in clinical practice and society. Our studies include experimental and clinical research, interventions, and cohort studies.
The CVC researchers conduct intervention studies including pharmacological interventions, lifestyle interventions, and device interventions. In addition, cohort studies are carried out to identify prognostic factors among the general population and populations at high risk of CVD. The role of co-morbidities such as renal disease, cancer, obesity, and diabetes is also examined.
The CVC translational approach and high-quality research have helped to reduce CVD-related deaths and, therefore, contribute to healthy ageing.
The combination of the regional approach adopted by the CVC and the numerous international collaborations has generated considerable results for patients, policymakers, and other stakeholders.
G-CURE aims to become a global scientific leader and service provider in the development of new pharmacological treatments for cardiovascular diseases, with a focus on heart failure, ischaemic heart disease, and atrial fibrillation. Originating from the Department of Cardiology of one of the most advanced university hospitals in Europe, G-CURE is a modern institute built on strong scientific foundations dating back to the eighteenth century. G-CURE offers unique skill sets and combined expertise to pharmaceutical, biotech and related industries, with services that include experimental animal studies, clinical trials, data analysis, and consultancy. Our expertise encompasses the full spectrum from studying pathophysiology resulting in novel mechanistic targets, to pre-clinical and Phase I, II and III drug development studies.
University Medical Center Groningen (UMCG)
Cardiovascular Center (CVC)
P.O. Box 196
9700 AD Groningen